🇺🇸 FDA
Pipeline program

C-4-29 Cells

PB04

Phase 1 mab active

Quick answer

C-4-29 Cells for Multiple Myeloma in Relapse is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Multiple Myeloma in Relapse
Phase
Phase 1
Modality
mab
Status
active

Clinical trials